GlassScriptPhysician profile
Maureen A Ploen
NPI 1306949813
$1,338.49
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,232 · 2022: $106.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $298.58 | 2021 | |
| Abbvie INC. | $153.42 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $143.81 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $115.90 | 2021 | |
| Csl Behring | $81.36 | 2021 | |
| Allergan, INC. | $52.31 | 2021 | |
| Adamas Pharmaceuticals, INC. | $49.66 | 2021 | |
| Lilly USA, LLC | $48.61 | 2021 | |
| Acorda Therapeutics, INC | $45.81 | 2021 | |
| Amneal Pharmaceuticals LLC | $42.57 | 2021 | |
| Amgen INC. | $40.67 | 2021 | |
| Merz Pharmaceuticals, LLC | $38.25 | 2021 | |
| Ge Healthcare | $38.07 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $34.68 | 2021 | |
| Tanabe Pharma America, INC. | $23.79 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $23.70 | 2021 | |
| Ucb, INC. | $20.22 | 2021 | |
| Grifols USA, LLC | $19.67 | 2021 | |
| Upsher-Smith Laboratories LLC | $18.78 | 2021 | |
| Banner Life Sciences, LLC | $17.96 | 2021 | |
| Pfizer INC. | $16.06 | 2021 | |
| Xeris Pharmaceuticals, INC. | $14.61 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Ploen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.